Advancing Fibromyalgia Management With a Novel Sublingual Formulation of Cyclobenzaprine

This monograph details the clinical efficacy and safety of TNX-102 SL, a sublingual formulation of cyclobenzaprine ...

AUGUST 5, 2025

Unraveling Fibromyalgia: Diagnostic Dilemmas and Therapeutic Complexities

This clinical review summarizes challenges related to the diagnosis and management of fibromyalgia, highlighting ...

MAY 27, 2025

Percutaneous Electrical Nerve Field Stimulation Alters White Matter Integrity in Fibromyalgia Patients

Percutaneous electrical nerve field stimulation can modify white matter integrity in patients with fibromyalgia ...

JULY 18, 2024

Antidepressants for Chronic Pain: Use Ubiquitous but Largely Unsubstantiated

Antidepressants are used in the management of chronic pain despite insufficient evidence of long-term efficacy, ...

SEPTEMBER 22, 2023

Virtual Reality Device Gets FDA Approval for Fibromyalgia, Low Back Pain

The FDA has granted breakthrough device designation to EaseVRx for the treatment of resistant fibromyalgia and ...

NOVEMBER 5, 2020

Rehab Expert: Pain Patients Denied Needed Opioids in Palliative Care

David, a 38-year-old father of four and five-year survivor of fungal meningitis, experiences the long-term effects ...

DECEMBER 26, 2017

Discovery of Neural Signature for Fibromyalgia Could Aid Diagnosis

Researchers at the University of Colorado Boulder have discovered a neural signature that identified fibromyalgia ...

MARCH 17, 2017

Study: Hydrocodone Rescheduling Affects Prescribing

Prescriptions for hydrocodone fixed-dose combination products have plummeted since the opioid was rescheduled from ...

FEBRUARY 21, 2017